135015-56-4 Usage
Uses
Used in Pharmaceutical Industry:
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[[(2-ethyl-4-quinolinyl)oxy]methyl]-, methyl ester is used as a potential pharmaceutical compound for its possible biological activity due to the presence of the quinolinyl group. This activity may be harnessed for the development of new drugs targeting various diseases or conditions.
Used in Chemical Industry:
In the chemical industry, [1,1'-Biphenyl]-2-carboxylic acid, 4'-[[(2-ethyl-4-quinolinyl)oxy]methyl]-, methyl ester may be utilized as an intermediate or building block in the synthesis of more complex molecules. Its aromatic and ester functionalities could be exploited in the creation of novel materials or chemicals with specific properties.
Further study and research would be necessary to fully understand the properties and potential applications of [1,1'-Biphenyl]-2-carboxylic acid, 4'-[[(2-ethyl-4-quinolinyl)oxy]methyl]-,
methyl ester, as its complex structure suggests a wide range of possibilities in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 135015-56-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,0,1 and 5 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 135015-56:
(8*1)+(7*3)+(6*5)+(5*0)+(4*1)+(3*5)+(2*5)+(1*6)=94
94 % 10 = 4
So 135015-56-4 is a valid CAS Registry Number.
135015-56-4Relevant academic research and scientific papers
QUINOLINE DERIVATIVES AND USE THEREOF AS ANGIOTENSIN II ANTAGONISTS
-
, (2008/06/13)
The invention concerns pharmaceutically useful novel compounds of the formula I, in which R 1, R 2, R 3, R 4, R 5, Ra, A, X and Z have the various meanings defined herein, and their non-toxic salts, and pharmaceutical compositions containing them. The novel compounds are of value in treating conditions such as hypertension and congestive heart failure. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment. STR1
New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4- (biphenylylmethoxy)quinoline derivatives
Bradbury,Allott,Dennis,Fisher,Major,Masek,Oldham,Pearce,Rankine,Revill,Roberts,Russell
, p. 4027 - 4038 (2007/10/02)
A novel series of nonpeptidic angiotensin II (AII) receptor antagonists is reported, derived from linkage of the biphenylcarboxylic acid or biphenylyltetrazole moiety found in previously described antagonists via a methyleneoxy chain to the 4-position of
